Hubert Senters here. Let’s take a look at VRTX. One of the biggest net losers today across the markets. And this is one of the cases where you’re going to be careful when you’re trading those biotechs. Biotechs they’re risky as the human ratio hope for a cure for anything like cancer or anything like that’s big. Unfortunately, a lot of those companies will go through phase one, phase two, phase three and then it will fail. I mean just because it’s hard not to crack. Sometimes it’s almost like you got a little bit more risk going against you. Just don’t repeat the failure if you fall for this more than a couple of times. Just know that you got a weakness like you’re. You can still invest in companies and stuff like that. You just got to stay a little bit careful with the pharmaceuticals because as soon as it get the cloud or the cloud goes bad they go crazy. You had an early warning system here. There was one sell signal. Here’s the second. Here is the third. There was the fourth. And then it sold off really hard probably because it’s new. I don’t follow this particular company. I didn’t trade it. Just because I’m not really huge in that vertical. But if you’re not into trading you now have an opportunity because there’s going to be a lot of fear and greed bound up in that gap trade. Good old-fashioned bracket trade on earnings there ladies and gentlemen. Long above $232. Short below $213. I’m going to be doing some in-depth sharing of how I use Ichimoku tomorrow at 11AM EST. I’m going to HYPERLINK you to the registration form. If you want to come check it out. Good luck. Hope it helps. See you on the next video. Hubert.